These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11772263)

  • 1. Experimental and emerging therapies for sepsis and septic shock.
    Añel RL; Kumar A
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1471-85. PubMed ID: 11772263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory therapies in sepsis and septic shock.
    Freeman BD; Natanson C
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging therapies for sepsis and septic shock.
    Oh HM
    Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of steroids in the treatment of severe sepsis and septic shock.
    Batzofin BM; Sprung CL; Weiss YG
    Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):735-43. PubMed ID: 21925074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Schunck WH; Falck JR; Malik KU
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(2):121-50. PubMed ID: 23013331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel agents in the therapy of endotoxic shock.
    Howe LM
    Expert Opin Investig Drugs; 2000 Jun; 9(6):1363-72. PubMed ID: 11060748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic options to improve the microcirculation in sepsis and septic shock].
    Ragaller M; Theilen H; Koch T
    Hamostaseologie; 2007 Feb; 27(1):59-63. PubMed ID: 17279278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant therapies for sepsis and shock: which are more effective?].
    Groeneveld AB; Beishuizen A; Appelmelk BJ; Girbes AR
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1718-22. PubMed ID: 11572169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group.
    Poeze M; Froon AH; Ramsay G; Buurman WA; Greve JW
    Shock; 2000 Oct; 14(4):421-8. PubMed ID: 11049104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in the treatment of sepsis.
    Sharma VK; Dellinger RP
    Expert Opin Investig Drugs; 2003 Feb; 12(2):139-52. PubMed ID: 12556210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy.
    De Kock I; Van Daele C; Poelaert J
    Acta Clin Belg; 2010; 65(5):323-9. PubMed ID: 21128559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies.
    Hauser B; Bracht H; Matejovic M; Radermacher P; Venkatesh B
    Anesth Analg; 2005 Aug; 101(2):488-498. PubMed ID: 16037166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock.
    Iskit AB; Guc O
    Acta Pharmacol Sin; 2003 Oct; 24(10):953-7. PubMed ID: 14531935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor antagonists as therapeutic strategy in sepsis.
    Dhainaut JF; Mira JP; Brunet F
    Prog Clin Biol Res; 1994; 388():277-93. PubMed ID: 7831364
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroids for septic shock: back from the dead? (Pro).
    Balk RA
    Chest; 2003 May; 123(5 Suppl):490S-9S. PubMed ID: 12740234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthase inhibition as therapy for sepsis: a decade of promise.
    Cobb JP
    Surg Infect (Larchmt); 2001; 2(2):93-100; discussion 100-1. PubMed ID: 12594864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and emerging therapies for sepsis.
    Healy DP
    Ann Pharmacother; 2002 Apr; 36(4):648-54. PubMed ID: 11918516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.